Animal & Veterinary
CVM Names Two to Senior Posts
by Joanne M. Kla
FDA Veterinarian Newsletter January/February 2003 Volume XVIII, No 1
The Center for Veterinary Medicine has recently filled the positions of Director, Office of Research and Deputy Director of the Office of New Animal Drug Evaluation.
Effective January 15, 2003, Dr. Linda Youngman accepted the position of Director, Office of Research (OR), on a permanent basis succeeding Dr. Norris Alderson. Dr. Youngman has been acting director for the past 1½ years. "During this time, she has demonstrated the leadership, team work and commitment that has been so important to the continuing success of OR and CVM. During her tenure, the quality of OR's science has received high recognition and the productivity of OR's scientists has remained high," said Dr. Stephen Sundlof, CVM Director. Dr. Youngman served as Deputy Director of OR from August 2000 to July 2002.
Prior to coming to CVM, Dr. Youngman worked at the University of Oxford (UK), Clinical Trial Service Unit & Epidemiological Studies Unit, as the Director of Laboratories responsible for conducting large, human clinical trials and epidemiological studies worldwide.
Dr. Youngman earned her B.S., M.S., and Ph.D. degrees from Cornell University in toxicology and biochemistry. She also received post-graduate training in Epidemiology and Medical Statistics at the London School of Hygiene and Tropical Medicine.
Dr. Bernadette Dunham joined CVM on December 16, 2002, as the new Deputy Director for the Office of New Animal Drug Evaluation (ONADE). ONADE's major responsibility is to review information submitted by drug sponsors to determine if data are adequate to support a drug's approval for marketing. Dr. Dunham comes to CVM from the American Veterinary Medical Association's Governmental Relations Division in Washington, D.C., where she was serving as Acting Director. Dr. Dunham had been with AVMA since 1995.
"I have worked with Bernadette for several years. I have a great respect for her accomplishments and professionalism in advancing AVMA's mission, and I am very gratified that she has elected to work for CVM," said Dr. Stephen Sundlof, CVM Director.
Dr. Dunham received her D.V.M. from the Ontario Veterinary College, University of Guelph, Guelph, Ontario, Canada. She was in private practice (companion animal) in Ontario for three years before moving to Boston, MA, where she received her Ph.D. from Boston University. Following her post-doctoral studies in Boston, she participated in a residency program in the Department of Pathology at the New York State College of Veterinary Medicine, Cornell University. In 1988, Dr. Dunham joined the faculty of the Department of Pharmacology at the State University of New York (SUNY) Health Science Center, Syracuse, NY where her research focused on the molecular regulation of cardiac gap junction proteins. Concurrently, she was the Director of Laboratory Animal Medicine, Department of Laboratory Animal Resources, from 1989-1995 at the SUNY Health Science Center, Syracuse, NY.
Dr. Dunham is also an Adjunct Professor with the Department of Biomedical Sciences and Pathobiology at the Virginia-Maryland Regional College of Veterinary Medicine in Blacksburg, VA, a position she has held since 1996. She lectures on a variety of topics from emerging issues and opportunities in veterinary medicine to the role of consensus building in policy development.
As Acting Director of the Governmental Relations Division (GRD) at AVMA, Dr. Dunham was responsible for directing and supervising the activities of the staff to ensure that all GRD operations complied with the objectives and mission of the AVMA as set by the AVMA Executive Board. She participated in the formation and execution of association policies, objectives, and programs as they relate to the association's strategic plan; with particular emphasis on Federal legislative and regulatory issues. Dr. Dunham's work also involved identifying Congressional and regulatory issues that may impact on the profession as well as developing strategies for response to these issues.
Joanne Kla is a Consumer Safety Officer on CVM's Communications Staff and Assistant Editor of the FDA Veterinarian.